Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
äŒæ¥ã³ãŒãBLCO
äŒç€ŸåBausch + Lomb Corp
äžå Žæ¥May 06, 2022
æé«çµå¶è²¬ä»»è
ãCEOãSaunders (Brenton L)
åŸæ¥å¡æ°13500
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«May 06
æ¬ç€Ÿæåšå°520 Applewood Crescent
éœåžVAUGHAN
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœCanada
éµäŸ¿çªå·L4K 4B4
é»è©±çªå·19082552864
ãŠã§ããµã€ãhttps://ir.bausch.com/
äŒæ¥ã³ãŒãBLCO
äžå Žæ¥May 06, 2022
æé«çµå¶è²¬ä»»è
ãCEOãSaunders (Brenton L)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã